SZSE •
Healthcare •
Drug Manufacturers - General •
Quote as of 06/12/2026
Company Profile
IndustryDrug Manufacturers - General
SectorHealthcare
ExchangeSZSE
Market Capitalization5,190.96 mln
Float172 mln
EPS
0.89
Decent
P / E
10.66
Fair value
Piotroski F-Score
5
/ 9
Neutral
Beneish M-Score
-2.79
Likely reliable
Relative Strength
3
/ 100
Severely lagging
Debt / Equity
0.81
Moderate leverage
Business Description
Founded in 1950 and headquartered in Hangzhou, China, Zhejiang Int'l Group is a long-established company that buys and sells a wide range of medical products. Its offerings include standard medicines, biological treatments, and traditional Chinese remedies, distributed to both businesses and individual customers.